Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to -$65000.0.

  • Insight Molecular Diagnostics' Other Working Capital Changes fell 11365.55% to -$65000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $229000.0, marking a year-over-year increase of 700.93%. This contributed to the annual value of $458000.0 for FY2024, which is 15841.84% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Other Working Capital Changes of -$65000.0 as of Q3 2025, which was down 11365.55% from $124000.0 recorded in Q2 2025.
  • Insight Molecular Diagnostics' Other Working Capital Changes' 5-year high stood at $1.1 million during Q1 2021, with a 5-year trough of -$1.0 million in Q2 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$27000.0 (2024), whereas its average is -$10421.1.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Other Working Capital Changes plummeted by 69538.46% in 2021 and then surged by 71025.64% in 2024.
  • Insight Molecular Diagnostics' Other Working Capital Changes (Quarter) stood at -$1.0 million in 2021, then soared by 49.31% to -$514000.0 in 2022, then surged by 72.96% to -$139000.0 in 2023, then soared by 175.54% to $105000.0 in 2024, then tumbled by 161.9% to -$65000.0 in 2025.
  • Its Other Working Capital Changes stands at -$65000.0 for Q3 2025, versus $124000.0 for Q2 2025 and $65000.0 for Q1 2025.